Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Urmila Mukund Thatte"'
Publikováno v:
Perspectives in Clinical Research, Vol 15, Iss 1, Pp 31-37 (2024)
Purpose and Aim: In COVID 19 pandemic, it was essential to document the functioning of the institutional ethics committee (IEC), how the organization adapted and faced challenges posed, thus forming the rationale behind this particular audit. The obj
Externí odkaz:
https://doaj.org/article/1bf7eacc7fcd40b6bb108578b3605b0d
Autor:
Brinal H Figer, Swastika S Lamture, Tanmay Gandhi, Ashnik Chauhan, Anchal Gvalani, Nithya Jaideep Gogtay, Urmila Mukund Thatte
Publikováno v:
Perspectives in Clinical Research, Vol 12, Iss 2, Pp 93-99 (2021)
Purpose: Clinical research in India has been besieged by controversies. While studies have addressed other stakeholders, few have addressed the patient. The present study was conducted to assess the extent of awareness and understanding about the nat
Externí odkaz:
https://doaj.org/article/5f031f31d5c4446cbccaa7e83f4d5330
Publikováno v:
Perspectives in Clinical Research, Vol 12, Iss 3, Pp 133-139 (2021)
Purpose: A committee chaired by Dr. Ranjit Roy Chaudhary suggested accreditation of investigators, sites and ethics committees to improve the quality of trial conduct in the country. Prior to accreditation, understanding the challenges faced at the s
Externí odkaz:
https://doaj.org/article/c119866fd4734f6d9a27b94e911f49e5
Autor:
Brinal H Figer, Jeffrey Pradeep Raj, Saket J Thaker, Nithya Jaideep Gogtay, Urmila Mukund Thatte
Publikováno v:
Perspectives in Clinical Research, Vol 12, Iss 4, Pp 193-198 (2021)
Background: Abnormal laboratory values are a common reason for the exclusion of participants in clinical studies, increasing the recruitment time and cost during conduct. The use of sample-specific reference intervals (RIs) may help to address this i
Externí odkaz:
https://doaj.org/article/e19c36581146418fac9bb85953e9c79d
Autor:
Vijaya Laxman Chaudhari, Charuta Jaykumar Godbole, Prajakta Parag Gandhe, Nithya Jaideep Gogtay, Urmila Mukund Thatte
Publikováno v:
Indian Journal of Community Medicine, Vol 46, Iss 4, Pp 727-730 (2021)
Background: Literature suggests that the presence of the current Bacillus Calmette Guerin (BCG) policy appears to mitigate COVID-19 disease burden but no information exists on the nature of the BCG strain and disease burden. Objectives: To study the
Externí odkaz:
https://doaj.org/article/90ef245d7cf74b44af8e53930b33d99f
Publikováno v:
Lung India, Vol 37, Iss 2, Pp 169-173 (2020)
The Global Initiative for Asthma (GINA) recently released their updated Global Strategy for Asthma Management and Prevention Guide (2019). The pocket guide for practicing clinicians states that “the 2019 GINA strategy report represents the most imp
Externí odkaz:
https://doaj.org/article/3b7e037e591e463d873e919244874f96
Publikováno v:
Perspectives in Clinical Research, Vol 13, Iss 3, Pp 172-173 (2022)
Externí odkaz:
https://doaj.org/article/f42b0718b6df473fb32c980dfd20e161
Publikováno v:
Perspectives in Clinical Research, Vol 9, Iss 3, Pp 123-126 (2018)
Purpose/Aim: The Adverse Drug Reaction [ADR] form is the source document for the Pharmacovigilance Programme of India [PvPI] and captures information first hand from the patient. The raw data from it then gets converted into an individual case safety
Externí odkaz:
https://doaj.org/article/7bd8f70c530a4a9daebefc47d3d53fec
Autor:
Miteshkumar Rajaram, Maurya, Sunanda, Gautam, Jeffrey Pradeep, Raj, Shruti, Saha, Sanchita, Ambre, Aishwarya, Thakurdesai, Aditya, Shah, Urmila Mukund, Thatte
Publikováno v:
Indian journal of pharmacology. 54(2)
CYP3A5 enzymes belong to the phase I Group of drug-metabolizing enzymes, which are involved in the metabolism of 50% of the drugs. Participants with CYP3A5 genotype: CYP3A5 *1/*1 are fast metabolizers of drugs and hence will require higher dosing. Wh